Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults

Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):272-8. doi: 10.1016/j.numecd.2011.04.005. Epub 2011 Aug 6.

Abstract

Background and aims: Leukocyte telomere length (LTL) is a novel marker of cardiovascular (CV) risk. The aim of the study was to investigate the major determinants of LTL in a healthy young population at very low CV risk.

Methods and results: LTL was determined in 82 healthy subjects (49M/33F; age37 ± 9yrs), normotensive and not taking any medication with different family history of cardiovascular disease (CVD) (24yes/58no). Fasting blood samples were drawn in all subjects for the determination of lipid profile, high sensitive C-reactive protein, uric acid, Plasminogen Activator Inhibitor-1 (PAI-1), LTL and Endothelial Progenitor Cell (EPC) number. LTL was assessed with a specific real-time PCR reaction in leukocyte DNA samples. LTL resulted inversely correlated with family history of CVD (t = 2.70; p = 0.009), age (r = -0.238; p = 0.032), waist circumference (r = -0.256; p = 0.02), triglycerides (r = -0.218; p = 0.049), PAI-1 (r = -0.288; p = 0.009) and directly correlated with HDL-cholesterol (r = 0.316; p = 0.004) and EPC number (r = 0.358; p = 0.002). At a multivariate analysis, family history of CVD (p = 0.013), EPC count (p = 0.003), and HDL-cholesterol (p = 0.017) were independently associated with LTL (r = 0.62).

Conclusion: LTL is independently associated to CV risk factors also in healthy young adults.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Blood Pressure
  • C-Reactive Protein / analysis
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases / genetics*
  • Cholesterol, HDL / blood*
  • Cross-Sectional Studies
  • Endothelial Cells / cytology
  • Female
  • Humans
  • Leukocytes / pathology*
  • Leukocytes / ultrastructure
  • Linear Models
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / blood
  • Real-Time Polymerase Chain Reaction
  • Risk Factors
  • Stem Cells / cytology*
  • Stem Cells / metabolism
  • Telomere / pathology*
  • Telomere / ultrastructure
  • Triglycerides / blood
  • Uric Acid / blood

Substances

  • Biomarkers
  • Cholesterol, HDL
  • Plasminogen Activator Inhibitor 1
  • Triglycerides
  • Uric Acid
  • C-Reactive Protein